NL-OMON49514已完成2 期
eoadjuvant trial on the efficacy of propranolol monotherapy in angiosarcoma. - propranolol in angiosarcoma
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
Trial is onging in other countries
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •oHistological proof of angiosarcoma
- •oPatients with primary, recurrent and metastasised disease are eligible;
- •oPatients with a window of at least 3 weeks before surgery or systemic therapy
- •oAge of 18 years or more;
- •oAble and willing to give written informed consent;
- •oWHO performance status of 0, 1 or 2;
- •oEvaluable disease according to RECIST 1.1 criteria; radiologic visible disease
- •is not obligated in patients with cutaneous angiosarcoma
- •oAt least one tumor lesion accessible to safely biopsy per clinical judgement
- •of the treating physician
排除标准
- •o Contraindication for propranolol therapy,
- •o Current treatment with β-blockade therapy.
- •o Any anticancer treatment within 30 days prior to receiving the first dose of
- •investigational treatment; with the exception of hormonal therapy for breast
- •o Concurrent treatment with an anticancer therapy: with the exception of
- •hormonal therapy for breast cancer.
- •o Pregnancy.
研究者
相似试验
已完成
3 期
Prospective multicenter clinical trial with the PRECIZION Presbyopic multifocal intraocular lens10047518CataractPresbyopiaNL-OMON41971OPHTEC BV10
已完成
4 期
A prospective randomised controlled multicentre trial comparing half-dose photodynamic therapy (PDT) with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (CSC).Chronic central serous chorioretinopathy10047060NL-OMON39842niversitair Medisch Centrum119
已完成
不适用
Optimizing propofol dosing for (preterm) newborn infants that need endotracheal intubatioNL-OMON45172Erasmus MC, Universitair Medisch Centrum Rotterdam91
已完成
不适用
Trigeminovascular effects of propranolol in migraine treatment10019231MigraineNL-OMON43388Inwendige Geneeskunde22
已完成
2 期
MoTriColor: A phase II study of vinorelbine in advanced BRAF-like colon cancerNL-OMON47411Antoni van Leeuwenhoek Ziekenhuis